Breast Cancer Drug Saves Lives but May Cause Rare Side Effect
A study reveals that tamoxifen, a life-saving breast cancer drug, can directly activate the PI3K pathway in the uterus, increasing the risk of secondary tumors without the need for genetic mutations, challenging previous assumptions about therapy-related cancers and opening avenues for safer treatments.
